Soft Tissue Sarcoma Market Set for Significant Growth at a CAGR of 7.9% During the Forecast Period (2026-2036), Driven by Novel Therapies and Expanding Treatment Landscape | DelveInsight

TBI-1301INT230-6Positive

AI Analysis

Summary

Market research report projects soft tissue sarcoma market growth at 7.9% CAGR (2026-2036) driven by novel therapies including TBI-1301 and INT230-6, improved diagnostics, and expanded treatment options.

Importance:2/10

Sentiment:

0.40

soft tissue sarcomamarket analysisnovel therapiestreatment landscape

Read the original article

Published by PR Newswire Pharma on July 15, 2026 2:31 PM

Read Original